Identification of dna methylation changes at cis-regulatory elements during early steps of hsc differentiation using tagmentation-based whole genome bisulfite sequencing

Cell Cycle

Volumn 13, Issue 22, 2014, Pages 3476-3487

  Lipka, Daniel B ^a   Wang, Qi ^a   Cabezas Wallscheid, Nina ^a,b   Klimmeck, Daniel ^a,b,c   Weichenhan, Dieter ^a   Herrmann, Carl ^a,d   Lier, Amelie ^a,b   Brocks, David ^a   Von Paleske, Lisa ^a,b   Renders, Simon ^a,b   Wünsche, Peer ^a,b   Zeisberger, Petra ^a,b   Gu, Lei ^a   Haas, Simon ^a   Essers, Marieke Ag ^a   Brors, Benedikt ^a   Eils, Roland ^a   Trumpp, Andreas ^a,b   Milsom, Michael D ^a   Plass, Christoph ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Hi STEM Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Differentiation; Dna methylation; Epigenetics; Haematopoietic stem cells; Progenitor cells

Indexed keywords

BISULFITE; CELL DNA; CYTOSINE; GENOMIC DNA;

ANIMAL CELL; ARTICLE; BLOOD CELL; BONE MARROW; CELL POPULATION; CIS ISOMER; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE SEQUENCE; GENOME ANALYSIS; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PROGENY; TAGMENTATION BASED WHOLE GENOME BISULFITE SEQUENCING; CELL DIFFERENTIATION; GENETIC EPIGENESIS; GENETICS; GENOME; HIGH THROUGHPUT SEQUENCING; REGULATORY SEQUENCE;

CELL DIFFERENTIATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENOME; HEMATOPOIETIC STEM CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 84920083648     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.973334     Document Type: Article

References (78)

1. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121:1109-21; PMID: 15989959; http://dx.doi.org/10.1016/j.cell.2005.05. 026.
2. Osawa M, Hanada K, Hamada H, Nakauchi H. Longterm lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273:242-5; PMID:8662508; http://dx.doi.org/ 10.1126/science.273.5272.242
3. Szilvassy SJ, Weller KP, Chen B, Juttner CA, Tsukamoto A, Hoffman R. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched longterm repopulating stem cells. Blood 1996; 88:3642-53; PMID:8896435
4. Yamamoto R, Morita Y, Ooehara J, Hamanaka S, Onodera M, Rudolph KL, Ema H, Nakauchi H. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 2013; 154:1112-26; PMID:23993099; http://dx. doi.org/10.1016/j.cell.2013.08.007
5. Cabezas-Wallscheid NK, Daniel, Hansson Jenny, Lipka, Daniel B, Reyes, Alejandro; Wang Qi, Weichenhan, et al. Identification of Regulatory Networks in HSCs and Their Immediate Progeny via Integrated Proteome, Transcriptome, and DNA Methylome Analysis. Cell stem cell 2014; PMID:25158935
6. Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair. Cell 2008; 135:1118-29; PMID:19062086; http://dx.doi.org/ 10.1016/j.cell.2008.10.048
7. Wilson A, Laurenti E, Trumpp A. Balancing dormant and self-renewing hematopoietic stem cells. Curr Opin Genet Dev 2009; 19:461-8; PMID:19811902; http:// dx.doi.org/10.1016/j.gde.2009.08.005
8. Gazit R,Garrison Brian S, Rao TataN, Shay T,Costello J, Ericson J, Kim F, Collins James J, Regev A,Wagers Amy J, et al. Transcriptome Analysis Identifies Regulators of Hematopoietic Stemand Progenitor Cells. Stem Cell Rep 2013; 1:266-80; PMID:24319662; http://dx.doi.org/ 10.1016/j.stemcr.2013.07.004
9. McKinney-Freeman S, Cahan P, Li H, Lacadie SA, Huang HT, Curran M, Loewer S, Naveiras O, Kathrein KL, Konantz M, et al. The transcriptional landscape of hematopoietic stem cell ontogeny. Cell Stem Cell 2012; 11:701-14; PMID:23122293; http:// dx.doi.org/10.1016/j.stem.2012.07.018
10. Kent DG, Dykstra BJ, Cheyne J, Ma E, Eaves CJ. Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells. Blood 2008; 112:560-7; PMID:18502833; http://dx. doi.org/10.1182/blood-2007-10-117820
11. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007; 128:669-81; PMID:17320505; http://dx.doi.org/10.1016/j.cell.2007.01.033
12. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet 2013; 14:204-20; PMID:23400093; http://dx.doi.org/ 10.1038/nrg3354
13. Waddington CH. The strategy of the genes; a discussion of some aspects of theoretical biology. 1957
14. Bock C, Beerman I, Lien WH, Smith ZD, Gu H, Boyle P, Gnirke A, Fuchs E, Rossi DJ, Meissner A. DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell 2012; 47:633-47; PMID:22841485; http://dx.doi.org/ 10.1016/j.molcel. 2012.06.019
15. Broske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M, Kuhl C, Enns A, Prinz M, Jaenisch R, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet 2009; 41:1207-15; PMID: 19801979; http://dx.doi.org/10.1038/ng.463
16. Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, Bock C, Vasanthakumar A, Gu H, Xi Y, et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2012; 44:23-31; http://dx.doi. org/10.1038/ng.1009
17. Trowbridge JJ, Snow JW, Kim J, Orkin SH. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 2009; 5:442-9; PMID:19796624; http://dx. doi.org/10.1016/j.stem.2009.08.016
18. Tadokoro Y, Ema H, Okano M, Li E, Nakauchi H. De novo DNA methyltransferase is essential for selfrenewal, but not for differentiation, in hematopoietic stem cells. J Exp Med 2007; 204:715-22; PMID: 17420264; http://dx.doi.org/10.1084/jem.20060750
19. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 24:132-8; PMID: 10655057; http://dx.doi.org/10.1038/72785
20. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553-67; PMID:21130701; http://dx.doi.org/10.1016/j.ccr.2010.11.015
21. Olk-Batz C, Poetsch AR, Nollke P, Claus R, Zucknick M, Sandrock I, Witte T, Strahm B, Hasle H, Zecca M, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 2011; 117:4871-80; PMID:21406719; http://dx.doi. org/10.1182/blood-2010-08-298968
22. Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Fruhwald M, Costello JF, Held WA, Yu L, Krahe R, et al. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood 2001; 97:3226-33; PMID:11342453; http://dx.doi.org/10.1182/blood.V97.10.3226
23. Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, Bembea M, Liu TH, Heerema NA, Rassenti L, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64:2424-33; PMID:15059895; http://dx. doi.org/10.1158/0008-5472.CAN-03-2870
24. Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, Martinez-Trillos A, Castellano G, Brun-Heath I, Pinyol M, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 2012; 44:1236-42; PMID:23064414; http://dx.doi.org/ 10.1038/ng.2443
25. Oakes CC, Claus R, Gu L, Assenov Y, Hullein J, Zucknick M, Bieg M, Brocks D, Bogatyrova O, Schmidt CR, et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discov 2014; 4:348-61; PMID:24356097; http://dx.doi.org/10.1158/2159-8290.CD-13-0349
26. Pei L, Choi JH, Liu J, Lee EJ, McCarthy B,Wilson JM, Speir E, Awan F, Tae H, Arthur G, et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics 2012; 7:567-78; PMID:22534504; http://dx.doi.org/ 10.4161/epi.20237
27. Brocks D, Assenov Y, Minner S, Bogatyrova O, Simon R, Koop C, Oakes C, Zucknick M, Lipka DB, Weischenfeldt J, et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Rep 2014; 8:798-806; PMID: 25066126; http://dx.doi.org/10.1016/j.celrep.2014. 06.053
28. Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368:2059-74; PMID:23634996; http://dx.doi.org/10.1056/ NEJMoa1301689
29. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478:64-9; PMID:21909114; http://dx.doi.org/10.1038/ nature10496
30. Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, Feng Z, Punt N, Daigle A, Bullinger L, et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 2011; 20:66-78; PMID:21741597; http://dx.doi.org/ 10.1016/j.ccr.2011.06.010
31. Krivtsov AV, Figueroa ME, Sinha AU, Stubbs MC, Feng Z, Valk PJ, Delwel R, Dohner K, Bullinger L, Kung AL, et al. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. Leukemia 2013; 27:852-60; PMID:23235717; http://dx.doi.org/ 10.1038/leu.2012.363
32. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ, Schifano E, Booth J, van PuttenW, Skrabanek L, et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010; 17:13-27; PMID:20060365; http:// dx.doi.org/10.1016/j.ccr.2009.11.020
33. Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E, Fernandez H, Tallman MS, Greally JM, Carraway H, et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114:3448-58; PMID:19652201; http://dx.doi.org/10.1182/blood-2009-01-200519
34. Jeong M, Sun D, Luo M, Huang Y, Challen GA, Rodriguez B, Zhang X, Chavez L, Wang H, Hannah R, et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat Genet 2014; 46: 17-23; PMID:24270360; http://dx.doi.org/10.1038/ ng.2836
35. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363:2424-33; PMID:21067377; http://dx.doi.org/10.1056/NEJMoa1005143
36. Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 2014; 506:328-33; PMID:24522528; http://dx.doi.org/ 10.1038/nature13038
37. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA. Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55:4531-5; PMID:7553622
38. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6; PMID:8790415; http://dx.doi.org/10.1073/pnas.93.18.9821
39. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55:4525-30; PMID: 7553621
40. Gu H, Bock C, Mikkelsen TS, Jäger N, Smith ZD, Tomazou E, Gnirke A, Lander ES, Meissner A. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 2010; 7:133-6; PMID:20062050; http://dx.doi.org/ 10.1038/nmeth.1414
41. Lister R, O'Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH, Ecker JR. Highly Integrated Single-Base Resolution Maps of the Epigenome in Arabidopsis. Cell 2008; 133:523-36; PMID:18423832; http://dx.doi.org/10.1016/j.cell.2008.03.029
42. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-22; PMID:19829295; http://dx.doi. org/10.1038/nature08514
43. Kawai J, Hirotsune S, Hirose K, Fushiki S, Watanabe S, Hayashizaki Y. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucl Acids Res 1993; 21:5604-8; PMID:8284204; http:// dx.doi.org/10.1093/nar/21.24.5604
44. Plass C, Shibata H, Kalcheva I, Mullins L, Kotelevtseva N, Mullins J, Kato R, Sasaki H, Hirotsune S, Okazaki Y, et al. Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet 1996; 14:106-9; PMID:8782830; http://dx.doi.org/10.1038/ ng0996-106
45. Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, Adamson E, Mercola D, McClelland M. Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 2005; 7:748-60; PMID:16207477; http:// dx.doi.org/10.1593/neo.05289
46. Huang TH, Perry MR, Laux DE. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999; 8:459-70; PMID:9949205; http://dx.doi. org/10.1093/hmg/8.3.459
47. Lippman Z, Gendrel AV, Colot V, Martienssen R. Profiling DNA methylation patterns using genomic tiling microarrays. Nat Methods 2005; 2:219-24; PMID:16163803; http://dx.doi.org/10.1038/ nmeth0305-219
48. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692-702; PMID:21593595; http://dx.doi.org/10.4161/ epi.6.6.16196
49. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E,et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16: 383-93; PMID:16449502; http://dx.doi.org/10.1101/ gr.4410706
50. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP, et al. Agedependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 2010; 20:440-6; PMID:20219944; http://dx.doi. org/10.1101/gr.103606.109
51. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454:766-70; PMID:18600261
52. Bock C, Tomazou EM, Brinkman AB, Muller F, Simmer F, Gu H, Jager N, Gnirke A, Stunnenberg HG, Meissner A. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotech 2010; 28:1106-14; http://dx.doi.org/10.1038/nbt.1681
53. Gu H, Smith ZD, Bock C, Boyle P, Gnirke A, Meissner A. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protocols 2011; 6:468-81; http://dx. doi.org/10.1038/nprot.2010.190
54. Ziller MJ, Gu H, Muller F, Donaghey J, Tsai LT, Kohlbacher O, De Jager PL, Rosen ED, Bennett DA, Bernstein BE, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013; 500:477-81; PMID:23925113; http://dx.doi.org/ 10.1038/nature12433
55. Adey A, Shendure J. Ultra-low-input, tagmentationbased whole-genome bisulfite sequencing. Genome Res 2012; 22:1139-43; PMID:22466172; http://dx.doi. org/10.1101/gr.136242.111
56. Miura F, Enomoto Y, Dairiki R, Ito T. Amplificationfree whole-genome bisulfite sequencing by post-bisulfite adaptor tagging. Nucl Acids Res 2012; 40:e136
57. Wang Q, Gu L, Adey A, Radlwimmer B, Wang W, Hovestadt V, Bahr M, Wolf S, Shendure J, Eils R, et al. Tagmentation-based whole-genome bisulfite sequencing. Nat Protoc 2013; 8:2022-32; PMID:24071908; http://dx.doi.org/10.1038/nprot.2013.118
58. Smallwood SA, Lee HJ, Angermueller C, Krueger F, Saadeh H, Peat J, Andrews SR, Stegle O, Reik W, Kelsey G. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat Meth 2014; advance online publication
59. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324:929-30; PMID:19372393; http://dx.doi.org/10.1126/science. 1169786
60. Ito S, Shen L, Dai Q,Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011; 333:1300-3; PMID:21778364; http://dx.doi.org/ 10.1126/science.1210597
61. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011; 333:1303-7; PMID:21817016; http://dx.doi.org/10.1126/science.1210944
62. Pfaffeneder T, Hackner B, Truss M, Munzel M, Muller M, Deiml CA, Hagemeier C, Carell T. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angewandte Chemie 2011; 50:7008-12; PMID:21721093; http://dx.doi.org/10.1002/anie.201103899
63. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930-5; PMID:19372391; http://dx.doi.org/10.1126/science.1170116
64. Song C-X, Yi C, He C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat Biotech 2012; 30:1107-16; http://dx.doi.org/ 10.1038/nbt.2398
65. Gifford CA, Ziller MJ, Gu H, Trapnell C, Donaghey J, Tsankov A, Shalek AK, Kelley DR, Shishkin AA, Issner R, et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell 2013; 153:1149-63; PMID:23664763; http://dx.doi. org/10.1016/j.cell.2013.04.037
66. Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang MD, Ren B. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet 2013; 45:1198-206; PMID:23995138; http://dx.doi.org/10.1038/ng.2746
67. Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 2013; 153:1134-48; PMID:23664764; http://dx.doi.org/ 10.1016/j.cell.2013.04.022
68. Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Scholer A, van Nimwegen E, Wirbelauer C, Oakeley EJ, Gaidatzis D, et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011; 480:490-5; PMID:22170606
69. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28:495-501; PMID:20436461; http://dx.doi.org/10.1038/nbt.1630
70. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50; PMID:16199517; http://dx. doi.org/10.1073/pnas.0506580102
71. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucl Acids Res 2010; 38: W214-20; PMID:20576703; http://dx.doi.org/ 10.1093/nar/gkq537
72. Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucl Acids Res 2013; 41:D377-86; PMID:23193289; http:// dx.doi.org/10.1093/nar/gks1118
73. Cedar H, Bergman Y. Epigenetics of haematopoietic cell development. Nat Rev Immunol 2011; 11:478-88; PMID:21660052; http://dx.doi.org/10.1038/nri2991
74. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:1089-93; PMID:11498579; http://dx.doi.org/10.1126/ science.1063443
75. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012; 482:339-46; PMID:22337053; http://dx.doi.org/10.1038/ nature10887
76. Rinn JL. lncRNAs: Linking RNA to Chromatin. Cold Spring Harb Perspect Biol 2014; 6; PMID:25085913; http://dx.doi.org/10.1101/cshperspect.a018614
77. Arab K, Park YJ, Lindroth AM, Schafer A, Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, et al. Long Noncoding RNA TARID Directs Demethylation and Activation of the Tumor Suppressor TCF21 via GADD45A. Mol Cell 2014; PMID: 25087872
78. Habibi E, Brinkman Arie B, Arand J, Kroeze Leonie I, Kerstens Hindrik HD, Matarese F, Lepikhov K, Gut M, Brun-Heath I, Hubner Nina C, et al. Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell 2013; 13:360-9; PMID:2385